Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 6/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.41 |
| ▸ | REN | P00797 | 3/20 | 0.41 |
| ▸ | CPB1 | P15086 | 1/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.40 |
| ▸ | NPY4R | P50391 | 5/20 | 0.40 |
| ▸ | NPY1R | P25929 | 4/20 | 0.40 |
| ▸ | NPY2R | P49146 | 3/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29665650 | 0.88 | NPY4R (0.42) | OPRK1OPRM1OPRD1NPY4RNPY1R | |
| SCHEMBL30082288 | 0.85 | NPY4R (0.42) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29468869 | 0.84 | VIPR2 (0.42) | OPRK1OPRM1OPRD1 | |
| SCHEMBL31510099 | 0.84 | CTSL (0.47) | OPRK1RENNPY4RNPY1RNPY2R | |
| SCHEMBL30541993 | 0.83 | OPRM1 (0.46) | OPRK1OPRM1OPRD1 | |
| SCHEMBL30202260 | 0.81 | NPY4R (0.46) | OPRK1RENNPY4RNPY1RNPY2R | |
| SCHEMBL21981319 | 0.80 | REN (0.53) | OPRK1RENCPB1CPB2NPY4R | |
| SCHEMBL21981320 | 0.80 | REN (0.53) | OPRK1RENCPB1CPB2NPY4R | |
| SCHEMBL30202298 | 0.80 | NPY4R (0.51) | RENNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31094178 | 0.80 | CTSL (0.46) | OPRM1OPRD1RENNPY4RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724472-A2 | GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS | Sun Pharmaceutical Industries Limited (IN) | 2026-04-15 | — | — | EP | disclosed |
| WO-2024252367-A2 | NOVEL GLP-1/GIP DUAL AND GLP-1/GCG DUAL RECEPTOR AGONISTS | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2024-12-12 | — | — | WO | disclosed |